Home » Topics » Regulatory » Patents

Patents
RSS

Lundbeck discloses PDE1 inhibitors

Aug. 26, 2015

Thomas Jefferson University and University of Pennsylvania present fusion proteins

Aug. 25, 2015

Regeneron designs human antibodies to PD-1

Aug. 25, 2015

Genentech and Roche disclose anti-influenza MAbs

Aug. 24, 2015

Shijiazhuang Yiling Pharmaceutical divulges VEGFR-2 inhibitors

Aug. 24, 2015

Cognition Therapeutics patents sigma-2 receptor antagonists

Aug. 24, 2015

Merck & Co. discloses FFAR1 agonists

Aug. 24, 2015

Bristol-Myers Squibb synthesizes AAK1 inhibitors

Aug. 21, 2015

AM-Pharma discloses phosphatase-like proteins

Aug. 21, 2015

CSIR scientists describe PDE5A inhibitors

Aug. 21, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...